UK Study Finds That COVID-19 Vaccines Offer High Protection Against Hospitalisation From Delta Variant


I swear, this is the fourth time I’ve had to write something about vaccines being effective against COVID-19 variants. Can’t we just all accept vaccination is the best way to protect ourselves from COVID-19, and leave it at that?

Anyway, if you aren’t bored of reading about vaccines, here’s what’s up.

UK Study Finds That COVID-19 Vaccines Offer High Protection Against Hospitalisation From Delta Variant

According to The Straits Times, a study conducted by Public Health England (PHE) showed that both the Pfizer-BioNTech and the AstraZeneca vaccines reduce hospitalisation for the Delta coronavirus variant by more than 90%. 

The Delta variant, otherwise known as the B1617 variant, has sparked concern worldwide following its role in India’s catastrophic coronavirus spike earlier in the year. 

The study showed that the Pfizer-BioNTech vaccine demonstrated a 96% effectiveness from hospitalisation, while the Oxford-AstraZeneca jab came close at 92%. 

These levels are similar to the vaccines’ effectiveness against the Alpha variant—which was first found in Southeastern England late last year—and demonstrates that a complete vaccination regimen continues to offer robust protection against severe disease.

The two vaccines were examined because they are the main vaccines used in the British vaccination drive, and a similar study has not been conducted on the Moderna vaccine.


How’s Singapore’s Vaccination Drive Going?

Just last week, Singapore extended its vaccination programme to those aged 12 to 39, the last age group to be made eligible for the vaccination, according to The Straits Times.

The announcement came after vaccine deliveries were confirmed to be adequate for an accelerated vaccination schedule over the next two months. 

About 49,000 doses are dispensed daily, and this increased pace of vaccine rollout is expected to be sustainable, according to Health Minister Ong Ye Kung.

Given the large numbers of those who fall under the age group, Singapore citizens will be given a two-week priority window to book their vaccination appointments, as the coronavirus has been revealed to check passports before deciding whom to infect.

More than 4.4 million doses of the vaccine have already been administered, with in excess of 2.5 million people receiving at least one dose.

Vaccination take-up rates have been optimistic, with approximately 85% of students and 65% of those aged 40 to 44 having received their first dose or booked an appointment to do so. In older age groups, the figure rises to about three quarters.

Those who wish to register for the vaccine can do so via this link. Once registered, the Ministry of Health (MOH) will issue a personalised booking link via SMS for appointments, though it may take up to two weeks to receive the message as more supplies gradually arrive.

Feature Image: (cortex-film / CornelPutan)

Fresh grads, you don’t need any experience to earn up to $4,200 with this “secret”:

Read Also: